Add BrightSurf on Google Email

JCI Journals


Forging a link between brain and bone

A recent study published in JCI Journals reveals a significant connection between the brain and bone health, with implications for osteoporosis treatment. The findings suggest that certain neurological factors contribute to the development of bone disorders, opening up new avenues for therapy.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 27, 2002

Treating metastatic disease with a modified herpesvirus

Researchers have successfully treated metastatic disease using a modified herpesvirus, providing a promising treatment option for patients with advanced cancer. The therapy has shown promise in early trials, demonstrating its potential as a novel approach to combatting this devastating disease.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 27, 2002

Microtumor-induced vascular development

Glioma cells induce angiogenesis by interacting with host vasculature and sprouting new vessels, defying the cooptation model. Vascular outgrowth occurs as a continuous process of growth and remodeling, starting early in tumor progression.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 13, 2002

Oxidative damage to eNOS by tissue peroxynitrite

Research reveals that peroxynitrite damages endothelial NO synthase (eNOS), promoting uncoupled catalysis and oxidative stress in vascular tissues. This damage can propagate to other susceptible enzymes, exacerbating inflammation and oxidative stress.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 13, 2002

Insulin in heart development

Research reveals insulin's impact on cardiac growth and development. Insulin signaling pathways regulate the expression of key genes involved in cardiac hypertrophy.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 27, 2002

A new route to branching morphogenesis

Researchers identified a novel pathway controlling branching morphogenesis, a critical process in development and tissue formation. This finding has implications for understanding diseases involving abnormal branching patterns.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 13, 2002

Cell interactions in spermatocyte apoptosis

Research on spermatocyte apoptosis highlights the role of cell-cell and cell-extracellular matrix interactions. Key findings include specific molecular pathways involved in regulating spermatocyte death, which may inform therapeutic strategies for male infertility and other reproductive disorders.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 13, 2002

A novel cardiac glycogen storage disease

A novel cardiac glycogen storage disease has been identified through research published in the Journal of Clinical Investigation. The study sheds new light on the genetic causes and consequences of this rare condition, offering potential avenues for improved diagnosis and therapy.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 30, 2002

Fas signaling and cardiac hypertrophy

Research on Fas signaling reveals its involvement in the development of cardiac hypertrophy, a condition characterized by abnormal heart growth. Understanding this mechanism is crucial for developing effective treatments to manage cardiac hypertrophy and associated diseases.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 30, 2002

Blocking transmission of cell-associated HIV

Researchers have developed a mouse model to study the transmission of cell-associated HIV in women, finding that hormonal treatments and agents disrupting lipid rafts can prevent infection. The study reveals the importance of understanding cell-associated HIV transmission for developing effective prevention strategies.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 16, 2002

Hammering cancer cell survivin

Researchers have discovered a new target for treating cancer cells that rely on survivin to survive. This finding offers new hope for patients with cancer who are struggling with this aggressive protein.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 16, 2002

Monitoring epithelial plasticity, one cell at a time

Researchers monitor epithelial cell plasticity to understand its potential applications in tissue engineering and regenerative medicine. By analyzing individual cells, scientists can gain insights into how tissues adapt and respond to changing conditions.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 2, 2002

CNS cell death in bacterial meningitis

Infants and adults are susceptible to bacterial meningitis-induced CNS cell death, leading to severe neurological outcomes. Researchers investigated the underlying mechanisms of this devastating condition, shedding light on potential therapeutic targets for treatment and prevention.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 2, 2002

The anti-inflammatory effect of apoptotic bodies

Researchers explored the anti-inflammatory properties of apoptotic bodies in various diseases, including IBD and osteoarthritis. They found that these bodies can modulate immune responses and reduce inflammation, offering new therapeutic targets for treating chronic inflammatory conditions.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 2, 2002

Glomerular fibrosis now all the RAGE

A recent study published in the Journal of Clinical Investigation reveals a critical role for RAGE protein in glomerular fibrosis, a major driver of chronic kidney disease. The research sheds light on potential therapeutic targets to mitigate this devastating condition.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 12, 2001

Phenotypic variability in cystic fibrosis

Researchers investigate phenotypic variability in cystic fibrosis, revealing its impact on disease progression and treatment outcomes. The study highlights the importance of personalized medicine approaches to better manage CF patients.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 28, 2001

Optimizing antiviral peptide vaccines

Researchers have developed optimized antiviral peptide vaccines that exhibit enhanced efficacy against various viral infections, including HIV and SARS-CoV-2. These improvements are attributed to the incorporation of specific amino acid sequences that enhance immune responses.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 28, 2001

Arsenic and old telomeres

Telomeres, protective caps on chromosome ends, are shorter in people exposed to arsenic, increasing cancer risk. Long-term arsenic exposure has been associated with accelerated telomere shortening, a potential biomarker for arsenic poisoning.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 14, 2001

Foxo1 and the insulin resistance of cultured kidney cells

Researchers discovered that Foxo1 is involved in regulating glucose metabolism and promoting insulin resistance in cultured kidney cells. Increased Foxo1 activity was linked to decreased insulin sensitivity, highlighting its potential as a therapeutic target for treating related disorders.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 31, 2001

DDR2 and hepatic fibrosis

Research has identified DDR2 as a key player in the development of hepatic fibrosis, a liver disease characterized by excessive scar tissue buildup. High levels of DDR2 expression have been linked to advanced fibrosis and poor patient outcomes.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 31, 2001

Leptin and obesity: All in the head?

Research suggests that leptin, a hormone involved in weight regulation, may be more closely tied to mental factors than previously thought. Studies have found that alterations in brain structure and function may play a key role in leptin-related obesity.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 10, 2001

The RANKL cytokine at 2.6 Å

The RANKL cytokine at 2.6 Å resolution provides detailed information on its structure and function in the body. Researchers used this high-resolution imaging technique to study RANKL's role in bone formation and immune system regulation.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 26, 2001

Censoring self-specific B cells

Researchers have developed a method to 'censor' self-specific B cells, which can help treat autoimmune diseases. This approach may lead to more effective treatments for conditions such as rheumatoid arthritis and lupus.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 26, 2001

Rethinking reverse cholesterol transport

Researchers reexamine the process of reverse cholesterol transport, a critical mechanism for removing excess cholesterol from peripheral tissues. The study reveals that this process may have both protective and detrimental effects on cardiovascular health.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 12, 2001

Two routes to cell death in the diseased kidney

Researchers have discovered two distinct pathways leading to cell death in the diseased kidney, which could lead to new therapeutic targets for kidney disease. These findings provide a better understanding of kidney pathology and may enable the development of more effective treatments.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 12, 2001

T cell responses in aplastic anemia

Research in aplastic anemia reveals crucial insights into immune system dysfunction and potential therapeutic targets. Patients with aplastic anemia display impaired T cell responses, indicating a critical link between immunodeficiency and disease progression.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 29, 2001

Integrins and signaling in psoriasis

Researchers investigate integrin signaling in psoriasis, discovering altered expression of key proteins involved in immune responses. This study sheds light on potential therapeutic targets for treatment of the chronic skin condition.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 15, 2001

Postraumatic vaccination for spinal cord injury

Researchers are exploring postraumatic vaccination as a potential treatment for spinal cord injuries, showing promise in promoting neural regeneration and recovery. Early studies suggest that this approach may improve functional outcomes and quality of life for affected individuals.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 15, 2001

Harnessing the autoimmune response

Researchers develop a technique to conjugate peptides to virus-like particles, generating high-titer antibodies that inhibit disease-causing cytokines. This approach shows promise in blocking or delaying onset of autoimmune diseases such as arthritis.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 1, 2001

The protective role of secreted CD14

Scientists propose sCD14 as a protective mechanism against LPS-mediated inflammation. Studies show that increasing sCD14 levels can neutralize LPS and reduce inflammatory cytokine secretion. The protein's role in sepsis treatment is still uncertain, but its discovery offers new hope for managing systemic effects of bacterial infections.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 1, 2001

GLUT4 in membrane ruffles

Researchers found GLUT4 inserted into plasma membranes at regions of membrane ruffling. High insulin and glucose levels impede this process, suggesting a novel explanation for muscle glucose homeostasis loss in diabetes. This study provides insight into the role of membrane-cytoskeletal interactions in regulating glucose uptake.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 1, 2001